GHAPPcast

GHAPPcast

Por: Gastroenterology & Hepatology Advanced Practice Providers (GHAPP)
This is the official podcast of The Gastroenterology & Hepatology Advanced Practice Providers (GHAPP), an association is dedicated to developing educational programs, providing professional advancement services, and assembling resources for—and guided by—advanced practice providers (APPs).

 

Through our peer-to-peer network, we seek to support their integral role in the specialty healthcare community by providing the most relevant and timely information and communication for the treatment of their patients with gastrointestinal (GI) disorders and chronic liver disease (CLD).
134 episodios disponibles

Latest episodes of the podcast GHAPPcast

Mostrando página 6 de 7

GHAPP PBC Podcast Series Part 1: Prevalence, Awareness and Identification of PBC 18/10/2024
GHAPP PBC Podcast Series Part 3: The Key Highlights of PBC at the GHAPP Conference 2024 18/10/2024
KOL Conversation: A New Treatment Option 15/10/2024
KOL Conversation: New & Emerging Treatment Considerations for PBC & PBC Pruritus 15/10/2024
Journal Club: A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis 03/10/2024
FAQ: What is MASH? 03/10/2024
Medication Review Video Module: What is Resmetirom and how does it work to treat MASH? 03/10/2024
FAQ: What are the consequences of NASH going untreated? 03/10/2024
FAQ: How is MASH severity staged? What would an ideal MASH NIT algorithm look like? 03/10/2024
Medication Review: What is the clinical profile of Resmetirom, including dosing schedules? 03/10/2024
GHAPPcast: Recognizing the Severity of MASH 03/10/2024
FAQ: Best practices to accelerate the time to finding the right therapy for your patients with IBS-C? 18/09/2024
GHAPPcast: Navigating IBS: Pathophysiology, Neuromodulators, and Patient-Centered Care 17/09/2024
FAQ: What does it mean for a biosimilar to be interchangeable and why is that important? 17/09/2024
FAQ: What resources do you use to understand the latest approaches to managing IBS-C patients? 17/09/2024
FAQ: What are some best practices in determining clinically meaningful “response” to therapy for IBS-C patients? 17/09/2024
GHAPPcast: Biosimilars and the Patient Perspective 17/09/2024
GHAPPcast: Mastering IBS-C: Diagnostic Strategies, Differentiation, and Management. 10/09/2024
FAQ: What is the Difference Between Biosimilars and Generics? 04/09/2024
FAQ: What Role Does a New Mechanism of Action Play in Your Prescribing Decisions of IBS-C Therapy? 26/08/2024
« Primera ‹ Anterior 1 ... 4 5 6 7 Siguiente › Última »
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA